SlideShare a Scribd company logo
ANTENATAL SCREENING
EXPERT GROUP
DR NARENDRA MALHOTRA
DR MALAARORA
DR RANJANA KHANNA
DR ABHA RANI SINHA
DR PRAGYA MISHRA
DR NAVNEET MAGON
DR GANPAT SAWANTA
Reference Material
• New WHO guidelines on antenatal care –
Systematic review BJOG 2016;123:519-28
• Guidelines by Government of western
Australia
• SOGC guideline on Prenatal Screening
• RCOG / NICE Guidelines
WHY SCREEN ?
Why Screen ?
1.Triage mothers to High Risk & Low Risk
2.Prevent Maternal Complications
3.Screen the fetus for
• Chromosomal errors
• Structural Defects
• Growth abnormalities
4.Decide the time and mode of safe
delivery
ADD SCREENING FOR N.C.D.HERE
THE PYRAMID OF ANTENATAL CARE
Post delivery continued screening
Routine Antenatal Care 1990s…….
Early scan to diagnose
pregnancy & dating
22-24 wks
Fetal defects
Anomaly scan
Routine Antenatal Care 2005
11-14 wks
Fetal defects
20-23 wks
P I P I P
The great
Ob syndrome
Routine Antenatal Care 2010
11-13+6 wks
Fetal defects
Chemical markers Major
Cardiac defects
Uterine artery Doppler
20-23 wks
Anomaly scan
FOGSI OLD CHECK LIST OF 2009,MODIFIED IN 2017 AT FOGSI T.O.G.
First Trimester
Second Trimester
Third Trimester
FIRST TRIMESTER
FIRST TRIMESTER
Body Mass Index – If high
•Prevent further weight gain
•Institute Life style modifications
•Medical Therapy – Metformin
•Nutrition Therapy – High fibre diet
•Daily Exercise
•Prepare for safe delivery
General Examination
• Heart – Murmurs
• Lungs – Rhonchi
• Breast – Lumps / Nipples
• Abdomen – Scars / Lumps
•Per Speculum – Discharge / Polyp / Erosion
LBC / HPV
• Anus – Sentinel Pile
Blood Pressure
• Hypertension – BP in both arms
Sitting position
Dissappearance of korotkov
• Hypotension – increase sodium/ potassium intake
• Screening test for PIH
 Placental Growth Factor (PlGF)
 S Flt
 s endoglin
 Uterine artery doppler flow indices
Screening for Anaemia
• Complete Blood count
• Peripheral Smear
• If Microcytic Hypochromic
Iron studies – Ferritin / Total Iron / TIBC
Haemoglobin Electrophoresis
• If Normocytic / Macrocytic
Serum Vitamin B12
Serum / Red cell Folate
Reticulocyte count
Blood group & Rhesus Antibodies
• If Rhesus Negative
• Partners Blood group – If negative –
• If positive – Indirect Coombs test
• If positive – Cordocentesis & fetal blood
transfusion with Rh negative blood at
periodic intervals
• Deliver at 34 weeks
Endocrine Screening
• Thyroid function test
• If abnormal, thyroid antibodies
• In PCO – screen for GDM early (HbA1C)
• If galactorrhea – Prolactin
• Serum Vitamin D
• Relaxin ?
Infection Screen
• Complete blood count /ESR
• Rubella antibodies
• Urine routine & microscopy
• Mid stream urine culture
• High Vaginal / Endo cervical swab /Wet Prep /
Vaginal pH / Chlamydia antibodies
(SOLVS + FVU PCR)
• HIV / Hep B / Hep C / VDRL
Bio
ch
e
m
ical S cre
e
ning
Various Integrated screening in
strategies (1st and 2nd trim)
Main strategies:
• Fully Integrated
• Step-wise sequential
• Contingent screening
NT
, PAPP
N
-T
A
,,P
F
A
b
P
-h
PC
-A
G
Ris
N
ko
es
rit
s
im
k a
et
s
e
timate
Final risAk
l
l
em
s
t
ia
mr
k
ae
t
er
:
s
All markers
NIPT
Low risk
1s1
t s
tr
tim
trie
m
se
te
sr
t:
er:
NT
, PA
1P
st
Pt-rA
im
, e
Fs
b
t-
e
h
r:
CG
2n
2
d
nt
d
rim
trie
m
s
e
te
sr
te
: r:
F
b
F
-
b
h
-
C
h
2
G
C
n
,
G
d
A
,
t
F
r
A
i
m
P
F
,
e
P
u
s
,
E
t
u
e
3
E
r
,
:
3
(
,
±
(
I
±
n
I
h
n
i
h
b
i
b
n
i
)
n
)
Fb-hCG, AFP, uE3, (± Inhibin)
Final risk estimate:
FA
inl
a
llm
ris
ak
rk
e
e
s
rts
imate:
CVS
Risk estimatH
e igh risN
kIP
C
T
VS
Borderline risk
No further
screening
LR HR
First trimester screening for
Preeclampsia
Maternal serum PIGF,
Mean arterial Blood pressure
- Implantation
- Maternal artery remodelling
Detection rate – 90%
0
10
20
30
False
positive
(%)
Doppler
12%
30%
PP13
9%
Doppler
& PP13
Non Invasive Prenatal Testing (NIPT)
• NIPT – 9 weeks onwards
• At least 4% fetal fraction to be identified
• Twin Pregnancy – confusing results
• Vanishing twin – confusing results
• If positive – CVS / Amniocentesis
CVS
•11-14 weeks
•Transcervical
•Check for chorionic villi under
microscope
•Risk of miscarriage 1%
•Need is obviated now due to NIPT
Amniocentesis
•15-18 weeks
•Risk of miscarriage < 1%
•To confirm diagnosis in positive
integrated screen and/or positive NIPT
•To screen known carriers for
chromosomally abnormal fetus
FIRST TRIMESTER
SCREENING FOR
CHROMOSOMAL
ANOMALIES
Screening in the 1st trimester
• Time window: 8 - 14 weeks
• Ultrasound Marker:
• NT
• Biochemical markers:
• PAPP-A
• Fb-hCG
• Marker combination:
• Combined test: NT, PAPP-A, Fb hCG
Screening for Trisomy 21 at 11- 14 weeks
2-stage (contingency) screening- UK system
USG (N.T.) AND DUAL MARKER FOR ALL
Fetal NT and
free BhCG and
PAPP-A at 12 wks
Very high risk
Very low risk
CVS
Reassure
Borderline
risk
Further
screening
Nasal bone
DV, TR
Screening for Trisomy 21 at 11- 14 weeks for
India
2-stage (contingency) screening proposed
RISK ESTIMATE BY ONLY USG N.T. AND OTHER MARKERS
Fetal NT
Nasal bone and
ductus venosus
tricuspid
regurgitation at 12
wks
Very high risk
Very low risk
CVS
Reassure
Borderline
risk
Further
screening
Free B hCG
PAPP-A
THIS WILL SAVE
TIME
MONEY
OPTIMUM USE OF OUR
SKILL
DOUBLE MARKER
TEST
Scan 20w NIPT
• MA+ NIPT(OPTIONAL)
• Dual Marker
• NT + NB + TR + DV
First
trimester
• Quad Marker
• Genetic Sonogram
Second
trimester
Integrated1
st and2nd trimesterscreening
DR – 97%
FPR – 2.5%
SO PROPOSAL IS INDIAN
CONTINGENT SCREEN
OR
INTEGRATED FIRSTAND
SECOND TRIMESTER
SCREEN
COMBINED FIRST TRIMESTER SCREEN
FOR RISK ESTIMATE…….
FOLLOWED BY COMBINED 2ND
TRIMESTER RISK SCREENING
99
COMBINED SCREENING & RISK ESTIMATION IN FIRST
TRIMESTER
1LOW LEVELS PREDICT PRE ECCLAMPSIA
2 LOW RISK NO FURTHER TEST (1 : 1000)
INTERMEDIATE RISK (100 : 999) TO PROCEED TO SECOND TRIMESTER SCREENING VS NIPT
HIGH RISK (1 : 99) TO GO FOR CVS / NIPT
ANTENATAL CHECKLIST
First Trimester Recommended Preferable
weight BMI
Blood pressure Mean Arterial Pressure
Haemoglobin Complete blood count/ Peripheral smear /
Hb Electrophoresis / HPLC
Blood group ABO & Rh (both partners)
Urine routine MSU culture
VDRL/ Hep B / HIV HCV / Rubella IgG
TSH Thyroid function test / Thyroid Antibodies
Vitamin D
DIPSI test 75gms 2 hours blood sugar Hb A1C / OGTT/ 6 point blood sugar test
Dating scan + NT
Double marker (free beta
HCG + PAPP A1 )
(Contingent Screen2
Cervical length
Uterine artery Doppler
NIPT
Placental Growth Factor
(PLGF)
Per speculum exam Pap Smear, Bacterial vaginosis &
Chlamydia screen
First Trimester
Second Trimester
Third Trimester
SECOND TRIMESTER
SCREENING
CERVICAL LENGTH SCREENING
ROUTINE TO PREVENT PRETERM
LABOUR AND FOR GUIDELINE FOR
CX STITCH
• ASYMPTOMATIC SINGLETON PREGNANCYATVS CL <25
MM IN SECOND TRIMESTER
• SCREEN AT 11-13 WEEKSAND THEN AT 22-22 WEEKS
RECENT EVIDENCE SAYS CX STITCH DOES NOT HELP AND
PROGESTERONE MAY BE THE ONLY TREATMENT OPTION
HERE.ROUTINE MCDONALD STITCH PRACTISE SHOULD BE
INDIVIDUALISED
SECOND
TRIMESTER
Second Trimester Recommended Preferable
18-24 weeks Repeat bloods (Hb /
blood sugar / TSH) &
urine test as indicated
Quadruple OR Triple
marker
NIPT
Anomaly scan 3D/4D scan/ Fetal
Echo
Uterine artery
Doppler
Cervical length
DIPSI screen 75 gms 2
hour blood sugar
6 Points Blood
Sugar HbA1C
Sequential Screening
•Quadruple marker – 15-18 weeks
•NIPT 9 week onwards
•Amniocentesis – 15 week onwards
COMBINED 2ND TRIMESTER SCREENING
ANOMALY SCAN
Screening for GDM
• HbA1C
• DIPSI one step screen 75 gms 2
hour
• Cut off of 140 mg/dl
• At 24 to 28 weeks
• Repeat at 32 weeks in high risk
women i.e Polyhydramnios /
previous GDM / Parents &
siblings diabetic
Screening for PIH
• Blood Pressure
• Water Retention – edema / rapid
weight gain
• Micro albuminuria
• Spot test – Urine Protein /Creatinine
ratio
• Ratio of PlGF / sFlt
• LDH raised in HELLP Syndrome
• Renal artery doppler
Vaccination
• Tetanus Toxoid – ONE DOSE
• Tdap –SECOND DOSE AT 24 WEEKS
• Influenza vaccine 24 weeks onwards
• hpB can be given if not immunised
• Targetted Vaccine in case of travel to
endemic areas
• Post partum – HPV vaccine
First Trimester
Second Trimester
Third Trimester
THIRD TRIMESTER
SCREEN
Abbreviations
Hb Haemoglobin
TSH Thyroid stimulating hormone
HbA1C Haemoglobin A1C
Scan,
NIPT Non invasive prenatal testing
plasma protein A
PlGF Placental growth factor
HCV Hepatitis C virus
HIV Human Immune defeciency virus
chromatography
GCT- Glucose Challenge Test
OGTT Oral glucose tolerance test
NT Scan- Nuchal Translucency
PAPP A- PregnancyAssociated
VDRL Venereal disease reference
Hep B hepatitis B virus
HPLC high performance liquid
Third
Trimester
Recommended Preferable
24 weeks
onwards
Repeat DIPSI Screen
TSH/Hb/Urine
HbA1C
Growth scan with liquor volume
& placental localisation
Fetal Doppler
velocimetry
Fetal movement count CTG (NST)
(6 in 2 hours) Modified
biophysical
Score
Doppler
velocimetry
THIRD TRIMESTER
INFECTION SCREEN
• GBS – Is routine screening required prior to
delivery ?
• Pelvic assessment – Does it improve your
decision for normal delivery ?
• Pelvic relaxation techniques / exercises like
walking / squatting / butterfly
NON USG SCREENING
FOR FETAL WELL
BEING
CARDIOTOCOGRAPHY
Cardiotocography
• Non Stress test vs Oxytocin Stress test
• When to start ? Post viability period 30
weeks
• How often to do ? Once a week
• What are the omnious signs –
Lack of BTB variation
Variable deaccelerations of cord
compression
Late deacceleration of fetal hypoxia
• Supplement with ST waveform analysis
• Fetal cord blood pH during labour
KICK CHART
Recording
•Every kick / roll is 1 movement
•Count 10 movements everyday
•Should be around 6 in 1 hour
•If < 6 movements in 2 hours
•Call doctor & come for CTG / USS
assessment
About baby’s movements
An active baby is usually a healthy baby. You
will feel your baby stretch, kick, roll and turn
every day. Some babies are more active than
others. All babies have periods of sleep during
which they are not as active. You will get to
know your baby’s pattern of movements and
when your baby is most active.
You should feel your baby’s movements
throughout the day, each day from 28 weeks of
pregnancy until the baby is born.
When during my pregnancy should I count
my baby’s movements?
Your health care provider may ask you
to count your baby’s movements once
every day.
If you think there is a decrease in your
baby’s movements this is an important sign that
your baby may not be well. Count your baby’s
movements to be sure that you feel at least 6
movements in 2 hours.
Reference:
Society of Obstetricians and Gynaecologists of Canada (2007).
Fetal Health Surveillance : Antepartum and Intrapartum Consensus
Guideline. Journal of Obstetrics and Gynaecology Canada. 29(9).
FETAL MOVEMENT
COUNT CHART
PLEASE BRING THIS CHART WITH YOU EACH
TIME YOU SEE THE DOCTOR/MIDWIFE
IMPORTANT PHONE NUMBERS:
DOCTOR:
MIDWIFE:
HOSPITAL:
DUE DATE:
OTHER INSTRUCTIONS:
For 24-hour nurse advice and health information call
Health Link Alberta:
1-866-408- LINK (5465)– Toll Free
In Calgary call 403-943- LINK (5465)
In Edmonton call 780-408-LINK (5465)
ADDRESS:
NAME:
HS0001-132 (2012/11)
How do I count my baby’s movements?
• Get into a comfortable position – lying on
your side or sitting. Place one or both of your
hands on your abdomen.
• Count each time that you feel your baby
move. If you feel many movements all at
once, count each movement that you feel.
• Write down the date and the time that you
start counting on the fetal movement chart.
• Make a mark on the chart each time your baby
moves.
• Stop counting when you have counted 6
movements.
• Write down the time you stopped counting.
• Do not count for more than 2 hours
What if I don’t feel 6 movements in 2 hours?
Count your baby’s movements once a day. You
should feel 6 or more movements in 2 hours.
If you count fewer than 6 movements in 2 hours
do not wait. Go to the hospital or birthing unit.
Your baby’s heart rate and movements will be
checked using a fetal monitor. This is called a
non-stress test or NST.
If you live too far from a hospital or birthing
unit, immediately contact your health care
provider for advice.
TWEAK Screening for alcoholism
• T – Tolerance (No of drinks one can hold)
• W- Worry about drinking
• E – Eye opener
• A- Amnesia
• K/C – Cut down on drinking
• To screen for fetal alcohol syndrome
• Antepartum fetal surveillance is the assessment of
fetal well being in utero before the onset of labor
• Early detection of fetus at risk so that timely
management to prevent further deterioration
• Also find out normal fetuses and avoid unnecessary
interventions
• Very high negative predictive value
• Very low positive predictive value
FETUS AT RISK
• PRE TERM
• POST TERM
• IUGR
• THICK MECONIUM
WITH SCANTY
FLUID
• INTRAUTERINE
INFECTION
• INTRAPARTUM
BLEEDING
FETUS AT
RELATIVE RISK
INJUDICIOUS USE OF
OXYTOCIN
EPIDURAL IN A CASE WITH
SOME COMPROMISE
DIFFICULT INSTRUMENTAL
DELIVERY/ MACROSOMIA/
MALPRESENTATION
ACUTE EVENTS (CORD
PROLAPSE, ABRUPTION,
SCAR RUPTURE)
SUSPICIOUS/ ABNORMAL
ADMISSION TEST
Admission assessment
Are any risk factors present?
Maternal problems
• Previous LSCS
• Pre-eclampsia
• Post-term pregnancy (>42
weeks)
• Prolonged membrane rupture
(>24 hours)
• Induced labour
• APH
• Other maternal disease
Fetal problems
• Growth restriction
• Prematurity
• Oligohydramnios
• Abnormal dopplers
• Multiple pregnancy
• Meconium stained liquor
• Breech presentation
INDICATION OF FETAL SURVEILLANCE
•Maternal conditions
• Hypertension
• Diabetes mellitus
• Heart Disease
• Chronic renal disease
• Acute febrile illness
• Pneumonia /asthma
• Epilepsy
• Collagen vascular disease
• Sickle cell disease
• Antiphospholipid syndrome
• Drug Abuse
• FETAL CONDITIONS
• Fetal growth restriction
• Rh isoimmunisation
• Fetal Cardiac arrythmia
• Hydrops fetalis
• Fetal infections
• PREGNANCY RELATED CONDITIONS
• Preeclampsia
• Multiple pregnancy
• Post term pregnancy
• Decreased fetal movements
• Abnormal placentation
• Placental abruption
• Oligohydramnios
• Polyhydramnios
• Unexplained stillbirth in a previous pregnancy
• Cholestasis of pregnancy
• PROM
• Poorly controlled Gestational Diabetes mellitus
The Various Methods of Antepartum
Fetal Surveillance
1) Clinical assessment by uterine growth
2) Fetal movement count by the mother
3) Ultrasound for fetal growth
4) Non stress test and cardiotocography
5) Vibroacoustic stimulation test
6) Contraction stress test
7) Nipple stimulation test
8) Biophysical profile
9) Modified biophysical profile
10) Doppler studies
11) Fetal lung maturation studies
12) Placental grading
Check list made a few years back…….NOW TO BE MODIFIED
SCREENING IN PREGNANCY
At booking (Recommended 3ANC) [Preferable 5]
General Physical exam Heart / Lungs / Breast /
Abdomen
In all trimesters
• Maternal weight /BMI
• Blood Pressure / Mean Arterial Pressure
• Urine dipstick (albumin sugar)
1LOW LEVELS PREDICT PRE ECCLAMPSIA
2 LOW RISK NO FURTHER TEST (1 : 1000)
INTERMEDIATE RISK (100 : 999) TO PROCEED TO SECOND TRIMESTER SCREENING VS NIPT
HIGH RISK (1 : 99) TO GO FOR CVS / NIPT
ANTENATAL CHECKLIST
First Trimester Recommended Preferable
weight BMI
Blood pressure Mean Arterial Pressure
Haemoglobin Complete blood count/ Peripheral smear /
Hb Electrophoresis / HPLC
Blood group ABO & Rh (both partners)
Urine routine MSU culture
VDRL/ Hep B / HIV HCV / Rubella IgG
TSH Thyroid function test / Thyroid Antibodies
Vitamin D
DIPSI test 75gms 2 hours blood sugar Hb A1C / OGTT/ 6 point blood sugar test
Dating scan + NT
Double marker (free beta
HCG + PAPP A1 )
(Contingent Screen2
Cervical length
Uterine artery Doppler
NIPT
Placental Growth Factor
(PLGF)
Per speculum exam Pap Smear, Bacterial vaginosis &
Chlamydia screen
Second Trimester Recommended Preferable
18-24 weeks Repeat bloods (Hb /
blood sugar / TSH) &
urine test as indicated
Quadruple OR Triple
marker
NIPT
Anomaly scan 3D/4D scan/ Fetal
Echo
Uterine artery
Doppler
Cervical length
DIPSI screen 75 gms 2
hour blood sugar
6 Points Blood
Sugar HbA1C
Abbreviations
Hb Haemoglobin GCT- Glucose Challenge Test
OGTT Oral glucose tolerance test
NT Scan- Nuchal Translucency
TSH Thyroid stimulating hormone
HbA1C Haemoglobin A1C
Scan,
NIPT Non invasive prenatal testing
plasma protein A
PlGF Placental growth factor
HCV Hepatitis C virus
HIV Human Immune defeciency virus
chromatography
PAPP A- PregnancyAssociated
VDRL Venereal disease reference
Hep B hepatitis B virus
HPLC high performance liquid
Third
Trimester
Recommended Preferable
24 weeks
onwards
Repeat DIPSI Screen
TSH/Hb/Urine
HbA1C
Growth scan with liquor volume
& placental localisation
Fetal Doppler
velocimetry
Fetal movement count CTG (NST)
(6 in 2 hours) Modified
biophysical
Score
Doppler
velocimetry
FIRST TRIMESTER
COMBINED SCREENING & RISK ESTIMATION IN FIRST
TRIMESTER
SECOND
TRIMESTER
COMBINED 2ND TRIMESTER SCREENING
THIRD TRIMESTER
Abbreviations
Hb Haemoglobin GCT- Glucose Challenge Test
OGTT Oral glucose tolerance test
NT Scan- Nuchal Translucency
TSH Thyroid stimulating hormone
HbA1C Haemoglobin A1C
Scan,
NIPT Non invasive prenatal testing
plasma protein A
PlGF Placental growth factor
HCV Hepatitis C virus
HIV Human Immune defeciency virus
chromatography
PAPP A- PregnancyAssociated
VDRL Venereal disease reference
Hep B hepatitis B virus
HPLC high performance liquid
Third
Trimester
Recommended Preferable
24 weeks
onwards
Repeat DIPSI Screen
TSH/Hb/Urine
HbA1C
Growth scan with liquor volume
& placental localisation
Fetal Doppler
velocimetry
Fetal movement count CTG (NST)
(6 in 2 hours) Modified
biophysical
Score
Doppler
velocimetry
Abbreviations
• Hb Haemoglobin
• GCT- Glucose Challenge Test
• TSH Thyroid stimulating hormone
• OGTT Oral glucose tolerance test
• HbA1C Haemoglobin A1C
• NT Scan- Nuchal Translucency Scan,
• NIPT Non invasive prenatal testing
• PAPPA- Pregnancy Associated plasma protein A
• PlGF Placental growth factor
• VDRL Venereal disease reference
• HCV Hepatitis C virus
• Hep B hepatitis B virus
• HIV Human Immune defeciency virus
• HPLC high performance liquid chromatography
Thankyou

More Related Content

Similar to maternal screening in pregnancy

Congenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.ppt
Congenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.pptCongenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.ppt
Congenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.ppt
ssuseree565d
 
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandunganPrenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
Hendrik Sutopo
 
Baseline serum chemistry in 1st trimester
Baseline serum chemistry in 1st trimesterBaseline serum chemistry in 1st trimester
Baseline serum chemistry in 1st trimester
Rohit Jain
 
Common Lab Investigations in pregnancy specific to each Trimester
Common Lab Investigations in pregnancy specific to each TrimesterCommon Lab Investigations in pregnancy specific to each Trimester
Common Lab Investigations in pregnancy specific to each Trimester
DrNisheethOza
 
INDEX TB GUIDELINE - EXTRA PULMONARY TB
INDEX TB GUIDELINE - EXTRA PULMONARY TBINDEX TB GUIDELINE - EXTRA PULMONARY TB
INDEX TB GUIDELINE - EXTRA PULMONARY TB
Dr.Akhilesh kunoor
 
Index tb guideline eptb final2
Index tb guideline  eptb final2Index tb guideline  eptb final2
Index tb guideline eptb final2
Dr.Akhilesh kunoor
 
Every fetus at risk
Every fetus at riskEvery fetus at risk
Every fetus at risk
NARENDRA MALHOTRA
 
Prenatal diagnosis
Prenatal diagnosisPrenatal diagnosis
Prenatal diagnosis
obgymgmcri
 
Management of immunised mother
Management of immunised motherManagement of immunised mother
Management of immunised mother
satya sesha rao
 
THE PRINCIPLES OF ANTENATAL CARE.pptx
THE PRINCIPLES OF ANTENATAL CARE.pptxTHE PRINCIPLES OF ANTENATAL CARE.pptx
THE PRINCIPLES OF ANTENATAL CARE.pptx
Iram Chaudhry
 
Approach to a case of female infertility dr monikha
Approach to a case of female infertility dr monikhaApproach to a case of female infertility dr monikha
Approach to a case of female infertility dr monikha
Monikha Ess Ess
 
Antenatal / prenatal diagnosis of genetic disorders / diseases . Dr. jaleel
Antenatal / prenatal diagnosis of genetic disorders / diseases . Dr. jaleelAntenatal / prenatal diagnosis of genetic disorders / diseases . Dr. jaleel
Antenatal / prenatal diagnosis of genetic disorders / diseases . Dr. jaleel
pmjaleelvld
 
prenatal genet.pptx
prenatal genet.pptxprenatal genet.pptx
prenatal genet.pptx
krts131j
 
Antenatal care and high risk assessment1
Antenatal care and high risk assessment1Antenatal care and high risk assessment1
Antenatal care and high risk assessment1
Pave Medicine
 
Intrauterine Growth Restriction.pptx
Intrauterine Growth Restriction.pptxIntrauterine Growth Restriction.pptx
Intrauterine Growth Restriction.pptx
NkosinathiManana2
 
genetic & genomic in prenatal diagnosis.pptx
genetic & genomic in prenatal diagnosis.pptxgenetic & genomic in prenatal diagnosis.pptx
genetic & genomic in prenatal diagnosis.pptx
Evita637753
 
Investigations in First Trimester Pregnancy
Investigations in First Trimester Pregnancy Investigations in First Trimester Pregnancy
Investigations in First Trimester Pregnancy
Lifecare Centre
 
Hematuria - evaluation and management
Hematuria - evaluation and managementHematuria - evaluation and management
Hematuria - evaluation and management
GovtRoyapettahHospit
 

Similar to maternal screening in pregnancy (20)

Congenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.ppt
Congenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.pptCongenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.ppt
Congenital_abnormalities,_prenatal_diagnosis_&_fetal_surveillance.pptx.ppt
 
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandunganPrenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
 
Baseline serum chemistry in 1st trimester
Baseline serum chemistry in 1st trimesterBaseline serum chemistry in 1st trimester
Baseline serum chemistry in 1st trimester
 
Common Lab Investigations in pregnancy specific to each Trimester
Common Lab Investigations in pregnancy specific to each TrimesterCommon Lab Investigations in pregnancy specific to each Trimester
Common Lab Investigations in pregnancy specific to each Trimester
 
Prenatal care
Prenatal carePrenatal care
Prenatal care
 
INDEX TB GUIDELINE - EXTRA PULMONARY TB
INDEX TB GUIDELINE - EXTRA PULMONARY TBINDEX TB GUIDELINE - EXTRA PULMONARY TB
INDEX TB GUIDELINE - EXTRA PULMONARY TB
 
Index tb guideline eptb final2
Index tb guideline  eptb final2Index tb guideline  eptb final2
Index tb guideline eptb final2
 
Prenatal[3]
Prenatal[3]Prenatal[3]
Prenatal[3]
 
Every fetus at risk
Every fetus at riskEvery fetus at risk
Every fetus at risk
 
Prenatal diagnosis
Prenatal diagnosisPrenatal diagnosis
Prenatal diagnosis
 
Management of immunised mother
Management of immunised motherManagement of immunised mother
Management of immunised mother
 
THE PRINCIPLES OF ANTENATAL CARE.pptx
THE PRINCIPLES OF ANTENATAL CARE.pptxTHE PRINCIPLES OF ANTENATAL CARE.pptx
THE PRINCIPLES OF ANTENATAL CARE.pptx
 
Approach to a case of female infertility dr monikha
Approach to a case of female infertility dr monikhaApproach to a case of female infertility dr monikha
Approach to a case of female infertility dr monikha
 
Antenatal / prenatal diagnosis of genetic disorders / diseases . Dr. jaleel
Antenatal / prenatal diagnosis of genetic disorders / diseases . Dr. jaleelAntenatal / prenatal diagnosis of genetic disorders / diseases . Dr. jaleel
Antenatal / prenatal diagnosis of genetic disorders / diseases . Dr. jaleel
 
prenatal genet.pptx
prenatal genet.pptxprenatal genet.pptx
prenatal genet.pptx
 
Antenatal care and high risk assessment1
Antenatal care and high risk assessment1Antenatal care and high risk assessment1
Antenatal care and high risk assessment1
 
Intrauterine Growth Restriction.pptx
Intrauterine Growth Restriction.pptxIntrauterine Growth Restriction.pptx
Intrauterine Growth Restriction.pptx
 
genetic & genomic in prenatal diagnosis.pptx
genetic & genomic in prenatal diagnosis.pptxgenetic & genomic in prenatal diagnosis.pptx
genetic & genomic in prenatal diagnosis.pptx
 
Investigations in First Trimester Pregnancy
Investigations in First Trimester Pregnancy Investigations in First Trimester Pregnancy
Investigations in First Trimester Pregnancy
 
Hematuria - evaluation and management
Hematuria - evaluation and managementHematuria - evaluation and management
Hematuria - evaluation and management
 

More from dimasfujiansyah1

Critical Appraisal
Critical AppraisalCritical Appraisal
Critical Appraisal
dimasfujiansyah1
 
Data presentation .pptx
Data presentation .pptxData presentation .pptx
Data presentation .pptx
dimasfujiansyah1
 
vaginaldischarge2-180305141234.pptx
vaginaldischarge2-180305141234.pptxvaginaldischarge2-180305141234.pptx
vaginaldischarge2-180305141234.pptx
dimasfujiansyah1
 
infectionsofthegenitaltract-partiii-iv-160202100956 (2).pptx
infectionsofthegenitaltract-partiii-iv-160202100956 (2).pptxinfectionsofthegenitaltract-partiii-iv-160202100956 (2).pptx
infectionsofthegenitaltract-partiii-iv-160202100956 (2).pptx
dimasfujiansyah1
 
kontrasepsi.pptx
kontrasepsi.pptxkontrasepsi.pptx
kontrasepsi.pptx
dimasfujiansyah1
 
infectionsofthegenitaltract-parti-160202092417.pptx
infectionsofthegenitaltract-parti-160202092417.pptxinfectionsofthegenitaltract-parti-160202092417.pptx
infectionsofthegenitaltract-parti-160202092417.pptx
dimasfujiansyah1
 
uterinefibroids-180412190811.pptx
uterinefibroids-180412190811.pptxuterinefibroids-180412190811.pptx
uterinefibroids-180412190811.pptx
dimasfujiansyah1
 
fibroids-191226053031.pptx
fibroids-191226053031.pptxfibroids-191226053031.pptx
fibroids-191226053031.pptx
dimasfujiansyah1
 
fibroids-150512150851-lva1-app6892.pptx
fibroids-150512150851-lva1-app6892.pptxfibroids-150512150851-lva1-app6892.pptx
fibroids-150512150851-lva1-app6892.pptx
dimasfujiansyah1
 
uterinefibroids-130120064643-phpapp02.pptx
uterinefibroids-130120064643-phpapp02.pptxuterinefibroids-130120064643-phpapp02.pptx
uterinefibroids-130120064643-phpapp02.pptx
dimasfujiansyah1
 
postnatalassessmentppt-190522071905.pptx
postnatalassessmentppt-190522071905.pptxpostnatalassessmentppt-190522071905.pptx
postnatalassessmentppt-190522071905.pptx
dimasfujiansyah1
 
pph-210510090823.pptx
pph-210510090823.pptxpph-210510090823.pptx
pph-210510090823.pptx
dimasfujiansyah1
 
pph-150512151237-lva1-app6892.pptx
pph-150512151237-lva1-app6892.pptxpph-150512151237-lva1-app6892.pptx
pph-150512151237-lva1-app6892.pptx
dimasfujiansyah1
 
obstetricalultrasound-120122082419-phpapp01.pptx
obstetricalultrasound-120122082419-phpapp01.pptxobstetricalultrasound-120122082419-phpapp01.pptx
obstetricalultrasound-120122082419-phpapp01.pptx
dimasfujiansyah1
 
pneumothorax-150828120943-lva1-app6891.pptx
pneumothorax-150828120943-lva1-app6891.pptxpneumothorax-150828120943-lva1-app6891.pptx
pneumothorax-150828120943-lva1-app6891.pptx
dimasfujiansyah1
 
antenatalcare-171226080558.pptx
antenatalcare-171226080558.pptxantenatalcare-171226080558.pptx
antenatalcare-171226080558.pptx
dimasfujiansyah1
 
antenatalcarefinal-190503155705 (1).pptx
antenatalcarefinal-190503155705 (1).pptxantenatalcarefinal-190503155705 (1).pptx
antenatalcarefinal-190503155705 (1).pptx
dimasfujiansyah1
 
antenatalcare-171226080558.pptx
antenatalcare-171226080558.pptxantenatalcare-171226080558.pptx
antenatalcare-171226080558.pptx
dimasfujiansyah1
 

More from dimasfujiansyah1 (20)

Critical Appraisal
Critical AppraisalCritical Appraisal
Critical Appraisal
 
Data presentation .pptx
Data presentation .pptxData presentation .pptx
Data presentation .pptx
 
PICO (1).pptx
PICO (1).pptxPICO (1).pptx
PICO (1).pptx
 
vaginaldischarge2-180305141234.pptx
vaginaldischarge2-180305141234.pptxvaginaldischarge2-180305141234.pptx
vaginaldischarge2-180305141234.pptx
 
infectionsofthegenitaltract-partiii-iv-160202100956 (2).pptx
infectionsofthegenitaltract-partiii-iv-160202100956 (2).pptxinfectionsofthegenitaltract-partiii-iv-160202100956 (2).pptx
infectionsofthegenitaltract-partiii-iv-160202100956 (2).pptx
 
kontrasepsi.pptx
kontrasepsi.pptxkontrasepsi.pptx
kontrasepsi.pptx
 
infectionsofthegenitaltract-parti-160202092417.pptx
infectionsofthegenitaltract-parti-160202092417.pptxinfectionsofthegenitaltract-parti-160202092417.pptx
infectionsofthegenitaltract-parti-160202092417.pptx
 
uterinefibroids-180412190811.pptx
uterinefibroids-180412190811.pptxuterinefibroids-180412190811.pptx
uterinefibroids-180412190811.pptx
 
fibroids-191226053031.pptx
fibroids-191226053031.pptxfibroids-191226053031.pptx
fibroids-191226053031.pptx
 
fibroids-150512150851-lva1-app6892.pptx
fibroids-150512150851-lva1-app6892.pptxfibroids-150512150851-lva1-app6892.pptx
fibroids-150512150851-lva1-app6892.pptx
 
uterinefibroids-130120064643-phpapp02.pptx
uterinefibroids-130120064643-phpapp02.pptxuterinefibroids-130120064643-phpapp02.pptx
uterinefibroids-130120064643-phpapp02.pptx
 
postnatalassessmentppt-190522071905.pptx
postnatalassessmentppt-190522071905.pptxpostnatalassessmentppt-190522071905.pptx
postnatalassessmentppt-190522071905.pptx
 
pph-210510090823.pptx
pph-210510090823.pptxpph-210510090823.pptx
pph-210510090823.pptx
 
pph-150512151237-lva1-app6892.pptx
pph-150512151237-lva1-app6892.pptxpph-150512151237-lva1-app6892.pptx
pph-150512151237-lva1-app6892.pptx
 
PPH
PPHPPH
PPH
 
obstetricalultrasound-120122082419-phpapp01.pptx
obstetricalultrasound-120122082419-phpapp01.pptxobstetricalultrasound-120122082419-phpapp01.pptx
obstetricalultrasound-120122082419-phpapp01.pptx
 
pneumothorax-150828120943-lva1-app6891.pptx
pneumothorax-150828120943-lva1-app6891.pptxpneumothorax-150828120943-lva1-app6891.pptx
pneumothorax-150828120943-lva1-app6891.pptx
 
antenatalcare-171226080558.pptx
antenatalcare-171226080558.pptxantenatalcare-171226080558.pptx
antenatalcare-171226080558.pptx
 
antenatalcarefinal-190503155705 (1).pptx
antenatalcarefinal-190503155705 (1).pptxantenatalcarefinal-190503155705 (1).pptx
antenatalcarefinal-190503155705 (1).pptx
 
antenatalcare-171226080558.pptx
antenatalcare-171226080558.pptxantenatalcare-171226080558.pptx
antenatalcare-171226080558.pptx
 

Recently uploaded

NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 

Recently uploaded (20)

NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 

maternal screening in pregnancy

  • 2. EXPERT GROUP DR NARENDRA MALHOTRA DR MALAARORA DR RANJANA KHANNA DR ABHA RANI SINHA DR PRAGYA MISHRA DR NAVNEET MAGON DR GANPAT SAWANTA
  • 3. Reference Material • New WHO guidelines on antenatal care – Systematic review BJOG 2016;123:519-28 • Guidelines by Government of western Australia • SOGC guideline on Prenatal Screening • RCOG / NICE Guidelines
  • 5. Why Screen ? 1.Triage mothers to High Risk & Low Risk 2.Prevent Maternal Complications 3.Screen the fetus for • Chromosomal errors • Structural Defects • Growth abnormalities 4.Decide the time and mode of safe delivery
  • 6. ADD SCREENING FOR N.C.D.HERE THE PYRAMID OF ANTENATAL CARE Post delivery continued screening
  • 7. Routine Antenatal Care 1990s……. Early scan to diagnose pregnancy & dating 22-24 wks Fetal defects Anomaly scan
  • 8. Routine Antenatal Care 2005 11-14 wks Fetal defects 20-23 wks P I P I P The great Ob syndrome
  • 9. Routine Antenatal Care 2010 11-13+6 wks Fetal defects Chemical markers Major Cardiac defects Uterine artery Doppler 20-23 wks Anomaly scan
  • 10. FOGSI OLD CHECK LIST OF 2009,MODIFIED IN 2017 AT FOGSI T.O.G.
  • 13.
  • 15. Body Mass Index – If high •Prevent further weight gain •Institute Life style modifications •Medical Therapy – Metformin •Nutrition Therapy – High fibre diet •Daily Exercise •Prepare for safe delivery
  • 16. General Examination • Heart – Murmurs • Lungs – Rhonchi • Breast – Lumps / Nipples • Abdomen – Scars / Lumps •Per Speculum – Discharge / Polyp / Erosion LBC / HPV • Anus – Sentinel Pile
  • 17. Blood Pressure • Hypertension – BP in both arms Sitting position Dissappearance of korotkov • Hypotension – increase sodium/ potassium intake • Screening test for PIH  Placental Growth Factor (PlGF)  S Flt  s endoglin  Uterine artery doppler flow indices
  • 18. Screening for Anaemia • Complete Blood count • Peripheral Smear • If Microcytic Hypochromic Iron studies – Ferritin / Total Iron / TIBC Haemoglobin Electrophoresis • If Normocytic / Macrocytic Serum Vitamin B12 Serum / Red cell Folate Reticulocyte count
  • 19. Blood group & Rhesus Antibodies • If Rhesus Negative • Partners Blood group – If negative – • If positive – Indirect Coombs test • If positive – Cordocentesis & fetal blood transfusion with Rh negative blood at periodic intervals • Deliver at 34 weeks
  • 20. Endocrine Screening • Thyroid function test • If abnormal, thyroid antibodies • In PCO – screen for GDM early (HbA1C) • If galactorrhea – Prolactin • Serum Vitamin D • Relaxin ?
  • 21. Infection Screen • Complete blood count /ESR • Rubella antibodies • Urine routine & microscopy • Mid stream urine culture • High Vaginal / Endo cervical swab /Wet Prep / Vaginal pH / Chlamydia antibodies (SOLVS + FVU PCR) • HIV / Hep B / Hep C / VDRL
  • 23. Various Integrated screening in strategies (1st and 2nd trim) Main strategies: • Fully Integrated • Step-wise sequential • Contingent screening NT , PAPP N -T A ,,P F A b P -h PC -A G Ris N ko es rit s im k a et s e timate Final risAk l l em s t ia mr k ae t er : s All markers NIPT Low risk 1s1 t s tr tim trie m se te sr t: er: NT , PA 1P st Pt-rA im , e Fs b t- e h r: CG 2n 2 d nt d rim trie m s e te sr te : r: F b F - b h - C h 2 G C n , G d A , t F r A i m P F , e P u s , E t u e 3 E r , : 3 ( , ± ( I ± n I h n i h b i b n i ) n ) Fb-hCG, AFP, uE3, (± Inhibin) Final risk estimate: FA inl a llm ris ak rk e e s rts imate: CVS Risk estimatH e igh risN kIP C T VS Borderline risk No further screening LR HR
  • 24. First trimester screening for Preeclampsia Maternal serum PIGF, Mean arterial Blood pressure - Implantation - Maternal artery remodelling Detection rate – 90% 0 10 20 30 False positive (%) Doppler 12% 30% PP13 9% Doppler & PP13
  • 25. Non Invasive Prenatal Testing (NIPT) • NIPT – 9 weeks onwards • At least 4% fetal fraction to be identified • Twin Pregnancy – confusing results • Vanishing twin – confusing results • If positive – CVS / Amniocentesis
  • 26. CVS •11-14 weeks •Transcervical •Check for chorionic villi under microscope •Risk of miscarriage 1% •Need is obviated now due to NIPT
  • 27. Amniocentesis •15-18 weeks •Risk of miscarriage < 1% •To confirm diagnosis in positive integrated screen and/or positive NIPT •To screen known carriers for chromosomally abnormal fetus
  • 29. Screening in the 1st trimester • Time window: 8 - 14 weeks • Ultrasound Marker: • NT • Biochemical markers: • PAPP-A • Fb-hCG • Marker combination: • Combined test: NT, PAPP-A, Fb hCG
  • 30. Screening for Trisomy 21 at 11- 14 weeks 2-stage (contingency) screening- UK system USG (N.T.) AND DUAL MARKER FOR ALL Fetal NT and free BhCG and PAPP-A at 12 wks Very high risk Very low risk CVS Reassure Borderline risk Further screening Nasal bone DV, TR
  • 31. Screening for Trisomy 21 at 11- 14 weeks for India 2-stage (contingency) screening proposed RISK ESTIMATE BY ONLY USG N.T. AND OTHER MARKERS Fetal NT Nasal bone and ductus venosus tricuspid regurgitation at 12 wks Very high risk Very low risk CVS Reassure Borderline risk Further screening Free B hCG PAPP-A THIS WILL SAVE TIME MONEY OPTIMUM USE OF OUR SKILL DOUBLE MARKER TEST Scan 20w NIPT
  • 32. • MA+ NIPT(OPTIONAL) • Dual Marker • NT + NB + TR + DV First trimester • Quad Marker • Genetic Sonogram Second trimester Integrated1 st and2nd trimesterscreening DR – 97% FPR – 2.5%
  • 33. SO PROPOSAL IS INDIAN CONTINGENT SCREEN OR INTEGRATED FIRSTAND SECOND TRIMESTER SCREEN COMBINED FIRST TRIMESTER SCREEN FOR RISK ESTIMATE……. FOLLOWED BY COMBINED 2ND TRIMESTER RISK SCREENING
  • 34. 99
  • 35.
  • 36. COMBINED SCREENING & RISK ESTIMATION IN FIRST TRIMESTER
  • 37. 1LOW LEVELS PREDICT PRE ECCLAMPSIA 2 LOW RISK NO FURTHER TEST (1 : 1000) INTERMEDIATE RISK (100 : 999) TO PROCEED TO SECOND TRIMESTER SCREENING VS NIPT HIGH RISK (1 : 99) TO GO FOR CVS / NIPT ANTENATAL CHECKLIST First Trimester Recommended Preferable weight BMI Blood pressure Mean Arterial Pressure Haemoglobin Complete blood count/ Peripheral smear / Hb Electrophoresis / HPLC Blood group ABO & Rh (both partners) Urine routine MSU culture VDRL/ Hep B / HIV HCV / Rubella IgG TSH Thyroid function test / Thyroid Antibodies Vitamin D DIPSI test 75gms 2 hours blood sugar Hb A1C / OGTT/ 6 point blood sugar test Dating scan + NT Double marker (free beta HCG + PAPP A1 ) (Contingent Screen2 Cervical length Uterine artery Doppler NIPT Placental Growth Factor (PLGF) Per speculum exam Pap Smear, Bacterial vaginosis & Chlamydia screen
  • 40. CERVICAL LENGTH SCREENING ROUTINE TO PREVENT PRETERM LABOUR AND FOR GUIDELINE FOR CX STITCH • ASYMPTOMATIC SINGLETON PREGNANCYATVS CL <25 MM IN SECOND TRIMESTER • SCREEN AT 11-13 WEEKSAND THEN AT 22-22 WEEKS RECENT EVIDENCE SAYS CX STITCH DOES NOT HELP AND PROGESTERONE MAY BE THE ONLY TREATMENT OPTION HERE.ROUTINE MCDONALD STITCH PRACTISE SHOULD BE INDIVIDUALISED
  • 42. Second Trimester Recommended Preferable 18-24 weeks Repeat bloods (Hb / blood sugar / TSH) & urine test as indicated Quadruple OR Triple marker NIPT Anomaly scan 3D/4D scan/ Fetal Echo Uterine artery Doppler Cervical length DIPSI screen 75 gms 2 hour blood sugar 6 Points Blood Sugar HbA1C
  • 43. Sequential Screening •Quadruple marker – 15-18 weeks •NIPT 9 week onwards •Amniocentesis – 15 week onwards
  • 46. Screening for GDM • HbA1C • DIPSI one step screen 75 gms 2 hour • Cut off of 140 mg/dl • At 24 to 28 weeks • Repeat at 32 weeks in high risk women i.e Polyhydramnios / previous GDM / Parents & siblings diabetic
  • 47. Screening for PIH • Blood Pressure • Water Retention – edema / rapid weight gain • Micro albuminuria • Spot test – Urine Protein /Creatinine ratio • Ratio of PlGF / sFlt • LDH raised in HELLP Syndrome • Renal artery doppler
  • 48. Vaccination • Tetanus Toxoid – ONE DOSE • Tdap –SECOND DOSE AT 24 WEEKS • Influenza vaccine 24 weeks onwards • hpB can be given if not immunised • Targetted Vaccine in case of travel to endemic areas • Post partum – HPV vaccine
  • 51. Abbreviations Hb Haemoglobin TSH Thyroid stimulating hormone HbA1C Haemoglobin A1C Scan, NIPT Non invasive prenatal testing plasma protein A PlGF Placental growth factor HCV Hepatitis C virus HIV Human Immune defeciency virus chromatography GCT- Glucose Challenge Test OGTT Oral glucose tolerance test NT Scan- Nuchal Translucency PAPP A- PregnancyAssociated VDRL Venereal disease reference Hep B hepatitis B virus HPLC high performance liquid Third Trimester Recommended Preferable 24 weeks onwards Repeat DIPSI Screen TSH/Hb/Urine HbA1C Growth scan with liquor volume & placental localisation Fetal Doppler velocimetry Fetal movement count CTG (NST) (6 in 2 hours) Modified biophysical Score Doppler velocimetry
  • 53. INFECTION SCREEN • GBS – Is routine screening required prior to delivery ? • Pelvic assessment – Does it improve your decision for normal delivery ? • Pelvic relaxation techniques / exercises like walking / squatting / butterfly
  • 54. NON USG SCREENING FOR FETAL WELL BEING
  • 56. Cardiotocography • Non Stress test vs Oxytocin Stress test • When to start ? Post viability period 30 weeks • How often to do ? Once a week • What are the omnious signs – Lack of BTB variation Variable deaccelerations of cord compression Late deacceleration of fetal hypoxia • Supplement with ST waveform analysis • Fetal cord blood pH during labour
  • 58. Recording •Every kick / roll is 1 movement •Count 10 movements everyday •Should be around 6 in 1 hour •If < 6 movements in 2 hours •Call doctor & come for CTG / USS assessment
  • 59. About baby’s movements An active baby is usually a healthy baby. You will feel your baby stretch, kick, roll and turn every day. Some babies are more active than others. All babies have periods of sleep during which they are not as active. You will get to know your baby’s pattern of movements and when your baby is most active. You should feel your baby’s movements throughout the day, each day from 28 weeks of pregnancy until the baby is born. When during my pregnancy should I count my baby’s movements? Your health care provider may ask you to count your baby’s movements once every day. If you think there is a decrease in your baby’s movements this is an important sign that your baby may not be well. Count your baby’s movements to be sure that you feel at least 6 movements in 2 hours. Reference: Society of Obstetricians and Gynaecologists of Canada (2007). Fetal Health Surveillance : Antepartum and Intrapartum Consensus Guideline. Journal of Obstetrics and Gynaecology Canada. 29(9). FETAL MOVEMENT COUNT CHART PLEASE BRING THIS CHART WITH YOU EACH TIME YOU SEE THE DOCTOR/MIDWIFE IMPORTANT PHONE NUMBERS: DOCTOR: MIDWIFE: HOSPITAL: DUE DATE: OTHER INSTRUCTIONS: For 24-hour nurse advice and health information call Health Link Alberta: 1-866-408- LINK (5465)– Toll Free In Calgary call 403-943- LINK (5465) In Edmonton call 780-408-LINK (5465) ADDRESS: NAME: HS0001-132 (2012/11) How do I count my baby’s movements? • Get into a comfortable position – lying on your side or sitting. Place one or both of your hands on your abdomen. • Count each time that you feel your baby move. If you feel many movements all at once, count each movement that you feel. • Write down the date and the time that you start counting on the fetal movement chart. • Make a mark on the chart each time your baby moves. • Stop counting when you have counted 6 movements. • Write down the time you stopped counting. • Do not count for more than 2 hours What if I don’t feel 6 movements in 2 hours? Count your baby’s movements once a day. You should feel 6 or more movements in 2 hours. If you count fewer than 6 movements in 2 hours do not wait. Go to the hospital or birthing unit. Your baby’s heart rate and movements will be checked using a fetal monitor. This is called a non-stress test or NST. If you live too far from a hospital or birthing unit, immediately contact your health care provider for advice.
  • 60. TWEAK Screening for alcoholism • T – Tolerance (No of drinks one can hold) • W- Worry about drinking • E – Eye opener • A- Amnesia • K/C – Cut down on drinking • To screen for fetal alcohol syndrome
  • 61. • Antepartum fetal surveillance is the assessment of fetal well being in utero before the onset of labor • Early detection of fetus at risk so that timely management to prevent further deterioration • Also find out normal fetuses and avoid unnecessary interventions • Very high negative predictive value • Very low positive predictive value
  • 62. FETUS AT RISK • PRE TERM • POST TERM • IUGR • THICK MECONIUM WITH SCANTY FLUID • INTRAUTERINE INFECTION • INTRAPARTUM BLEEDING FETUS AT RELATIVE RISK INJUDICIOUS USE OF OXYTOCIN EPIDURAL IN A CASE WITH SOME COMPROMISE DIFFICULT INSTRUMENTAL DELIVERY/ MACROSOMIA/ MALPRESENTATION ACUTE EVENTS (CORD PROLAPSE, ABRUPTION, SCAR RUPTURE) SUSPICIOUS/ ABNORMAL ADMISSION TEST
  • 63. Admission assessment Are any risk factors present? Maternal problems • Previous LSCS • Pre-eclampsia • Post-term pregnancy (>42 weeks) • Prolonged membrane rupture (>24 hours) • Induced labour • APH • Other maternal disease Fetal problems • Growth restriction • Prematurity • Oligohydramnios • Abnormal dopplers • Multiple pregnancy • Meconium stained liquor • Breech presentation
  • 64. INDICATION OF FETAL SURVEILLANCE •Maternal conditions • Hypertension • Diabetes mellitus • Heart Disease • Chronic renal disease • Acute febrile illness • Pneumonia /asthma • Epilepsy
  • 65. • Collagen vascular disease • Sickle cell disease • Antiphospholipid syndrome • Drug Abuse • FETAL CONDITIONS • Fetal growth restriction • Rh isoimmunisation • Fetal Cardiac arrythmia
  • 66. • Hydrops fetalis • Fetal infections • PREGNANCY RELATED CONDITIONS • Preeclampsia • Multiple pregnancy • Post term pregnancy • Decreased fetal movements • Abnormal placentation • Placental abruption
  • 67. • Oligohydramnios • Polyhydramnios • Unexplained stillbirth in a previous pregnancy • Cholestasis of pregnancy • PROM • Poorly controlled Gestational Diabetes mellitus
  • 68. The Various Methods of Antepartum Fetal Surveillance 1) Clinical assessment by uterine growth 2) Fetal movement count by the mother 3) Ultrasound for fetal growth 4) Non stress test and cardiotocography 5) Vibroacoustic stimulation test 6) Contraction stress test 7) Nipple stimulation test 8) Biophysical profile 9) Modified biophysical profile 10) Doppler studies 11) Fetal lung maturation studies 12) Placental grading
  • 69. Check list made a few years back…….NOW TO BE MODIFIED
  • 70. SCREENING IN PREGNANCY At booking (Recommended 3ANC) [Preferable 5] General Physical exam Heart / Lungs / Breast / Abdomen In all trimesters • Maternal weight /BMI • Blood Pressure / Mean Arterial Pressure • Urine dipstick (albumin sugar)
  • 71. 1LOW LEVELS PREDICT PRE ECCLAMPSIA 2 LOW RISK NO FURTHER TEST (1 : 1000) INTERMEDIATE RISK (100 : 999) TO PROCEED TO SECOND TRIMESTER SCREENING VS NIPT HIGH RISK (1 : 99) TO GO FOR CVS / NIPT ANTENATAL CHECKLIST First Trimester Recommended Preferable weight BMI Blood pressure Mean Arterial Pressure Haemoglobin Complete blood count/ Peripheral smear / Hb Electrophoresis / HPLC Blood group ABO & Rh (both partners) Urine routine MSU culture VDRL/ Hep B / HIV HCV / Rubella IgG TSH Thyroid function test / Thyroid Antibodies Vitamin D DIPSI test 75gms 2 hours blood sugar Hb A1C / OGTT/ 6 point blood sugar test Dating scan + NT Double marker (free beta HCG + PAPP A1 ) (Contingent Screen2 Cervical length Uterine artery Doppler NIPT Placental Growth Factor (PLGF) Per speculum exam Pap Smear, Bacterial vaginosis & Chlamydia screen
  • 72. Second Trimester Recommended Preferable 18-24 weeks Repeat bloods (Hb / blood sugar / TSH) & urine test as indicated Quadruple OR Triple marker NIPT Anomaly scan 3D/4D scan/ Fetal Echo Uterine artery Doppler Cervical length DIPSI screen 75 gms 2 hour blood sugar 6 Points Blood Sugar HbA1C
  • 73. Abbreviations Hb Haemoglobin GCT- Glucose Challenge Test OGTT Oral glucose tolerance test NT Scan- Nuchal Translucency TSH Thyroid stimulating hormone HbA1C Haemoglobin A1C Scan, NIPT Non invasive prenatal testing plasma protein A PlGF Placental growth factor HCV Hepatitis C virus HIV Human Immune defeciency virus chromatography PAPP A- PregnancyAssociated VDRL Venereal disease reference Hep B hepatitis B virus HPLC high performance liquid Third Trimester Recommended Preferable 24 weeks onwards Repeat DIPSI Screen TSH/Hb/Urine HbA1C Growth scan with liquor volume & placental localisation Fetal Doppler velocimetry Fetal movement count CTG (NST) (6 in 2 hours) Modified biophysical Score Doppler velocimetry
  • 74.
  • 76. COMBINED SCREENING & RISK ESTIMATION IN FIRST TRIMESTER
  • 80. Abbreviations Hb Haemoglobin GCT- Glucose Challenge Test OGTT Oral glucose tolerance test NT Scan- Nuchal Translucency TSH Thyroid stimulating hormone HbA1C Haemoglobin A1C Scan, NIPT Non invasive prenatal testing plasma protein A PlGF Placental growth factor HCV Hepatitis C virus HIV Human Immune defeciency virus chromatography PAPP A- PregnancyAssociated VDRL Venereal disease reference Hep B hepatitis B virus HPLC high performance liquid Third Trimester Recommended Preferable 24 weeks onwards Repeat DIPSI Screen TSH/Hb/Urine HbA1C Growth scan with liquor volume & placental localisation Fetal Doppler velocimetry Fetal movement count CTG (NST) (6 in 2 hours) Modified biophysical Score Doppler velocimetry
  • 81. Abbreviations • Hb Haemoglobin • GCT- Glucose Challenge Test • TSH Thyroid stimulating hormone • OGTT Oral glucose tolerance test • HbA1C Haemoglobin A1C • NT Scan- Nuchal Translucency Scan, • NIPT Non invasive prenatal testing • PAPPA- Pregnancy Associated plasma protein A • PlGF Placental growth factor • VDRL Venereal disease reference • HCV Hepatitis C virus • Hep B hepatitis B virus • HIV Human Immune defeciency virus • HPLC high performance liquid chromatography